|
CHD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.595190E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.861830E-02 |
| Normal-vs-Stage2 |
2.639800E-01 |
| Normal-vs-Stage3 |
1.604770E-01 |
| Normal-vs-Stage4 |
2.041800E-01 |
| Stage1-vs-Stage2 |
8.270600E-01 |
| Stage1-vs-Stage3 |
9.361600E-01 |
| Stage1-vs-Stage4 |
3.757400E-01 |
| Stage2-vs-Stage3 |
8.196600E-01 |
| Stage2-vs-Stage4 |
3.699800E-01 |
| Stage3-vs-Stage4 |
3.721600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.657000E-03 |
| Normal-vs-AfricanAmerican |
5.800200E-02 |
| Normal-vs-Asian |
1.263390E-01 |
| Caucasian-vs-AfricanAmerican |
7.578400E-01 |
| Caucasian-vs-Asian |
9.962400E-01 |
| AfricanAmerican-vs-Asian |
9.085000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.340900E-03 |
| Normal-vs-Female |
3.260000E-03 |
| Male-vs-Female |
2.399000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.431220E-01 |
| Normal-vs-Extreme_Weight |
2.990400E-02 |
| Normal-vs-Obese |
1.272250E-02 |
| Normal-vs-Extreme_Obese |
6.209200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.401200E-01 |
| Normal_Weight-vs-Obese |
8.093800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.050800E-01 |
| Extreme_Weight-vs-Obese |
6.618800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.765000E-01 |
| Obese-vs-Extreme_Obese |
4.240400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.401340E-03 |
| Normal-vs-Age(41-60Yrs) |
3.62369999999945E-05 |
| Normal-vs-Age(61-80Yrs) |
3.087200E-01 |
| Normal-vs-Age(81-100Yrs) |
9.816600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.703200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.128000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.842200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.367700E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.628500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.912400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.979240E-04 |
| Normal-VS-Type2 PRCC |
6.812200E-01 |
| Normal-VS-KIRP CIMP |
2.757900E-02 |
| Normal-VS-Unclassified PRCC |
6.085900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.598100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.180600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.033000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.830600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.117600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.737800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.927000E-01 |
| Normal-vs-N1 |
2.628100E-02 |
| Normal-vs-N2 |
4.014200E-02 |
| N0-vs-N1 |
3.473500E-02 |
| N0-vs-N2 |
1.962840E-01 |
| N1-vs-N2 |
7.306800E-01 |
|
|
